List of Peloton Therapeutics patents

List of Peloton Therapeutics patents

List of Agile Software Corporation patents

List of Domtar patents

List of KALYPSYS, INC. patents

List of funding rounds for Solidus Labs

List of companies in Anchor Capital's investment portfolio

Patents where

Current Assignee

Name

is

Peloton Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10144711 Aryl ethers and uses thereof	Patent 10144711 was granted and assigned to Peloton Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10144711	December 4, 2018
	‌ US Patent 9908845 Aryl ethers and uses thereof	Patent 9908845 was granted and assigned to Peloton Therapeutics on March, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	9908845	March 6, 2018
	‌ US Patent 9896418 Aryl ethers and uses thereof	Patent 9896418 was granted and assigned to Peloton Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	9896418	February 20, 2018
	‌ US Patent 10155726 Substituted pyridines and uses thereof	Patent 10155726 was granted and assigned to Peloton Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10155726	December 18, 2018
	‌ US Patent 10278942 Compositions for use in treating pulmonary arterial hypertension	Patent 10278942 was granted and assigned to Peloton Therapeutics on May, 2019 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10278942	May 7, 2019
	‌ US Patent 9969689 Aryl ethers and uses thereof	Patent 9969689 was granted and assigned to Peloton Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	9969689	May 15, 2018
	‌ US Patent 9796697 Tricyclic inhibitors of HIF-2-alpha and uses thereof	Patent 9796697 was granted and assigned to Peloton Therapeutics on October, 2017 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	9796697	October 24, 2017
	‌ US Patent 10335388 Combination therapy of a HIF-2-alpha inhibitor and an immunotherapeutic agent and uses thereof	Patent 10335388 was granted and assigned to Peloton Therapeutics on July, 2019 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10335388	July 2, 2019
	‌ US Patent 10807948 Aromatic compounds and uses thereof	Patent 10807948 was granted and assigned to Peloton Therapeutics on October, 2020 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10807948	October 20, 2020
	‌ US Patent 10786480 Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof	Patent 10786480 was granted and assigned to Peloton Therapeutics on September, 2020 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10786480	September 29, 2020
	‌ US Patent 10597366 Aryl ethers and uses thereof	Patent 10597366 was granted and assigned to Peloton Therapeutics on March, 2020 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10597366	March 24, 2020
	‌ US Patent 9884843 Cyclic sulfone and sulfoximine analogs and uses thereof	Patent 9884843 was granted and assigned to Peloton Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	9884843	February 6, 2018
	‌ US Patent 10040767 Benzimidazole derivatives and uses thereof	Patent 10040767 was granted and assigned to Peloton Therapeutics on August, 2018 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	10040767	August 7, 2018
	‌ US Patent RE49948 Aryl ethers and uses thereof	Patent RE49948 was granted and assigned to Peloton Therapeutics on April, 2024 by the United States Patent and Trademark Office.	Peloton Therapeutics	Peloton Therapeutics		United States Patent and Trademark Office	RE49948	April 30, 2024

14 results

0 selected

14 results

0 selected